Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.92B | 5.98B | 6.42B | 6.69B | 6.24B |
| Total Depreciation and Amortization | 701.00M | 659.00M | 734.00M | 831.00M | 929.00M |
| Total Amortization of Deferred Charges | 734.00M | 734.00M | 685.00M | 685.00M | 685.00M |
| Total Other Non-Cash Items | 11.00M | 154.00M | 351.00M | 949.00M | 1.29B |
| Change in Net Operating Assets | -2.52B | -1.72B | -6.06B | -7.09B | -5.58B |
| Cash from Operations | 4.85B | 5.81B | 2.13B | 2.07B | 3.57B |
| Capital Expenditure | -1.17B | -1.26B | -1.26B | -1.25B | -1.27B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.69B | -4.81B | -1.11B | -1.03B | -1.03B |
| Divestitures | 367.00M | 363.00M | 399.00M | 399.00M | -- |
| Other Investing Activities | 1.74B | 535.00M | -2.59B | -2.97B | -2.39B |
| Cash from Investing | -2.75B | -5.17B | -4.56B | -4.84B | -4.70B |
| Total Debt Issued | 7.26B | 7.99B | 3.29B | 3.24B | 1.58B |
| Total Debt Repaid | -3.28B | -2.50B | -548.00M | -177.00M | -433.00M |
| Issuance of Common Stock | 147.00M | 221.00M | 245.00M | 228.00M | 206.00M |
| Repurchase of Common Stock | -3.35B | -3.01B | -2.12B | -2.54B | -2.72B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.52B | -1.51B | -1.48B | -1.45B | -1.42B |
| Other Financing Activities | -16.00M | 2.00M | 11.00M | 10.00M | 9.00M |
| Cash from Financing | -748.00M | 1.19B | -609.00M | -688.00M | -2.79B |
| Foreign Exchange rate Adjustments | -5.00M | -6.00M | 3.00M | -8.00M | -2.00M |
| Miscellaneous Cash Flow Adjustments | -66.00M | -66.00M | -20.00M | -21.00M | -- |
| Net Change in Cash | 1.27B | 1.76B | -3.05B | -3.49B | -3.92B |